82 related articles for article (PubMed ID: 16416461)
1. Can risperidone and olanzapine in elderly patients with dementia and other mental disorders be discontinued?
Shah A
Int J Geriatr Psychiatry; 2006 Feb; 21(2):140-6. PubMed ID: 16416461
[TBL] [Abstract][Full Text] [Related]
2. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
Martin H; Slyk MP; Deymann S; Cornacchione MJ
J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
[TBL] [Abstract][Full Text] [Related]
3. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
4. How safe are antipsychotics in dementia?
BMJ Group
Drug Ther Bull; 2007 Nov; 45(11):81-5. PubMed ID: 18165678
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).
Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G
Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
8. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
Ruths S; Straand J; Nygaard HA; Aarsland D
Int J Geriatr Psychiatry; 2008 Sep; 23(9):889-95. PubMed ID: 18306150
[TBL] [Abstract][Full Text] [Related]
9. The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.
Kinon BJ; Stauffer VL; McGuire HC; Kaiser CJ; Dickson RA; Kennedy JS
J Am Med Dir Assoc; 2003; 4(4):189-94. PubMed ID: 12837139
[TBL] [Abstract][Full Text] [Related]
10. Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting.
Kilzieh N; Todd-Stenberg JA; Kennedy A; Wood AE; Tapp AM
J Clin Psychopharmacol; 2008 Feb; 28(1):74-7. PubMed ID: 18204345
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration.
Ritchie CW; Chiu E; Harrigan S; MacFarlane S; Mastwyk M; Halliday G; Hustig H; Hall K; Hassett A; O'Connor DW; Opie J; Nagalingam V; Snowdon J; Ames D
Int J Geriatr Psychiatry; 2006 Feb; 21(2):171-9. PubMed ID: 16416458
[TBL] [Abstract][Full Text] [Related]
12. [Mortality rates in patients with Alzheimer's disease treated with atypical neuroleptic drugs].
Vilalta-Franch J; Lopez-Pousa S; Garre-Olmo J; Turon-Estrada A; Pericot-Nierga I
Rev Neurol; 2008 Feb 1-15; 46(3):129-34. PubMed ID: 18297617
[TBL] [Abstract][Full Text] [Related]
13. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
Ren XS; Lee AF; Huang YH; Hamed A; Herz L; Miller DR; Kazis LE
J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
[TBL] [Abstract][Full Text] [Related]
15. What happened to patients with behavioural and psychological symptoms of dementia (BPSD) after the Committee on Safety in Medicines (CSM) guidelines?
Raju J; Sikdar S; Krishna T
Int J Geriatr Psychiatry; 2005 Sep; 20(9):898-9. PubMed ID: 16116573
[No Abstract] [Full Text] [Related]
16. Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents.
Ren XS; Qian S; Lee AF; Herz L; Miller DR; Kazis LE
J Clin Pharm Ther; 2006 Feb; 31(1):57-65. PubMed ID: 16476121
[TBL] [Abstract][Full Text] [Related]
17. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
Taylor DM; Wright T; Libretto SE;
J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
[TBL] [Abstract][Full Text] [Related]
18. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
van Marum RJ; Jansen PA
Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
[TBL] [Abstract][Full Text] [Related]
19. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
Barnett MJ; Wehring H; Perry PJ
J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
